Isolation and Characterization of Circulating Tumor Cells from Patients with Localized and Metastatic Prostate Cancer-Reference-Cited by-同舟云学术

Isolation and Characterization of Circulating Tumor Cells from Patients with Localized and Metastatic Prostate Cancer

Published:2010-03-31 Issue:25 Volume:2 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Stott Shannon L.¹²³,Lee Richard J.⁴⁵,Nagrath Sunitha¹²³,Yu Min⁴,Miyamoto David T.⁴⁶,Ulkus Lindsey⁴,Inserra Elizabeth J.⁴,Ulman Matthew⁴,Springer Simeon⁴,Nakamura Zev⁴,Moore Alessandra L.¹,Tsukrov Dina I.¹,Kempner Maria E.⁴,Dahl Douglas M.²⁷,Wu Chin-Lee⁴⁸,Iafrate A. John⁴⁸,Smith Matthew R.⁴⁵,Tompkins Ronald G.²³,Sequist Lecia V.⁴⁵,Toner Mehmet¹²³,Haber Daniel A.⁴⁵,Maheswaran Shyamala³⁴

Affiliation:

1. Center for Engineering in Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.

2. Shriners Hospital for Children, Harvard Medical School, Boston, MA 02114, USA.

3. Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.

4. Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA.

5. Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.

6. Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.

7. Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.

8. Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.

Abstract

Automated imaging of prostate-specific cancer cells from the blood provides a measure of circulating tumor cell half-life after tumor resection.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference31 articles.

1. Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant.;Fehm T.;Clin. Cancer Res.,2002

2. Changes in circulating carcinoma cells in patients with metastatic prostate cancer correlate with disease status

3. Circulating tumor cells predict survival in patients with metastatic prostate cancer

4. High detection rate of circulating tumor cells in blood of patients with prostate cancer using telomerase activity

5. Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer

Cited by 474 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extracellular vesicle-derived biomarkers in prostate cancer care: Opportunities and challenges;Cancer Letters;2024-10

2. Circulating tumor cells: from new biological insights to clinical practice;Signal Transduction and Targeted Therapy;2024-09-02

3. Decoding the interplay between genetic and non-genetic drivers of metastasis;Nature;2024-05-15

4. Fuyuan decoction prevents nasopharyngeal carcinoma metastasis by inhibiting circulating tumor cells/ endothelial cells interplay and enhancing anti-cancer immune response;Frontiers in Pharmacology;2024-04-25

5. Microfluidics-Based Technologies for the Assessment of Castration-Resistant Prostate Cancer;Cells;2024-03-26